Hyperfine announces results from NEURO PMR study

Hyperfine (HYPR) announced results from the NEURO PMR study, presented at the American Society of Neuroimaging annual meeting in San Juan, Puerto Rico on January 16. NEURO PMR is the first prospective, multi-center, real-world study to evaluate the clinical utility and patient experience of portable MRI compared to standard-of-care MRI in outpatient neurology clinics. Two sites-DENT Neurologic Institute and Texas Neurology-enrolled 125 patients with neurologic conditions commonly seen in the outpatient setting, including headache, dementia, multiple sclerosis follow-up, and tumor surveillance. Patients received brain imaging on both the portable Swoop system and a conventional high-field MRI, enabling direct modality comparisons. Portable MRI demonstrated 92% concordance with standard MRI in identifying the presence or absence of intracranial pathology during a blinded review by independent neuroradiologists. In unblinded paired image reviews incorporating clinical history, concordance increased to 98%, as assessed by a neurologist and neuroimager. Patients reported that they were four times more likely to choose it over standard MRI. Across all experience measures-including comfort, anxiety, claustrophobia, noise, and overall satisfaction-portable MRI was rated superior to standard MRI.